Skip to content

Acorda Therapeutics (ACOR.Q) Announces Deal to Commercialize Parkinson’s Treatment in Spain

Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize INBRIJA® 33 mg in Spain.

 

Read full article here: https://equity.guru/2021/07/acorda-therapeutics-acor-q-taking-pills-in-inbrija-announces-agreement-to-commercialize-parkinsons-treatment-in-spain/

Related Posts

More on